PET developer Naviscan has received the CE Mark for both its high-resolution positron emission mammography (PEM) scanner and PET-guided biopsy accessory.
The approval enables the company to market the system in Europe, where it has set up distribution in 13 countries, Naviscan said. The firm has already received the first two orders for the system in Germany and Switzerland.Naviscan's PEM gets CE Mark
Latest in Nuclear Medicine
Ratio Therapeutics partners with Macrocyclics
June 13, 2025
Radium-223 safety confirmed in long-term study
June 2, 2025